Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
| dc.contributor.author | Barkoff, Alex-Mikael | |
| dc.contributor.author | Kastrin, Tamara | |
| dc.contributor.author | Seme, Katja | |
| dc.contributor.author | Vitek, Marta Grgič | |
| dc.contributor.author | Mertsola, Jussi | |
| dc.contributor.author | He, Qiushui | |
| dc.contributor.organization | fi=InFLAMES Lippulaiva|en=InFLAMES Flagship| | |
| dc.contributor.organization | fi=biolääketieteen laitos|en=Institute of Biomedicine| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.68445910604 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.77952289591 | |
| dc.converis.publication-id | 470941132 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/470941132 | |
| dc.date.accessioned | 2025-08-28T00:07:52Z | |
| dc.date.available | 2025-08-28T00:07:52Z | |
| dc.description.abstract | <p>In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.<br></p> | |
| dc.identifier.eissn | 1080-6059 | |
| dc.identifier.jour-issn | 1080-6040 | |
| dc.identifier.olddbid | 205229 | |
| dc.identifier.oldhandle | 10024/188256 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/54125 | |
| dc.identifier.url | http://doi.org/10.3201/eid3011.231393 | |
| dc.identifier.urn | URN:NBN:fi-fe2025082792848 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Barkoff, Alex-Mikael | |
| dc.okm.affiliatedauthor | Mertsola, Jussi | |
| dc.okm.affiliatedauthor | He, Qiushui | |
| dc.okm.discipline | 3111 Biomedicine | en_GB |
| dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | Centers for Disease Control and Prevention (CDC) | |
| dc.publisher.country | United States | en_GB |
| dc.publisher.country | Yhdysvallat (USA) | fi_FI |
| dc.publisher.country-code | US | |
| dc.relation.doi | 10.3201/eid3011.231393 | |
| dc.relation.ispartofjournal | Emerging Infectious Diseases | |
| dc.relation.issue | 11 | |
| dc.relation.volume | 30 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/188256 | |
| dc.title | Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia | |
| dc.year.issued | 2024 |
Tiedostot
1 - 1 / 1